HDFC Pharma and Healthcare Fund

Direct–Growth is the plan and option we treat as this fund's main page, so search engines are pointed there. Everything below is this filing's own data.

Fund basics

Everything the NAV says

Computed from 764 published NAVs between 4 Oct 2023 and 9 Nov 2026 — 3.1 years of history. Nothing here is an estimate; it is arithmetic on what the fund actually printed.

How it has moved

Return over time (%)

Anything over a year is annualised (CAGR); shorter windows are absolute. The benchmark row is the index's own Total Return Index, as published by NSE, measured to 9 Nov 2026. The category row is the median Regular plan in Sectoral / Thematic — the middle fund, not a ranking, and a median rather than an average so that one mis-stated scheme cannot move it. As on 9 Nov 2026.

Risk measures

Risk-free rate 6.5%. The benchmark row is the index's NSE Total Return Index. Beta and alpha need the index as a reference, so the benchmark's own row leaves them blank.

Against its benchmark

Regressed on the 36 months this fund and NIFTY 500 TRI both have, using NSE's own Total Return Index for it. Alpha is Jensen's — the return left over after the market move this fund's own beta would predict.

Up and down capture are the pair worth reading together: a fund that takes 95% of the rises but only 80% of the falls is doing something a headline CAGR will never show you.

Risk

Risk-free rate 6.5%, roughly the 10-year government bond.

The worst it has been

A drawdown is the fall from a previous high to the low that followed it. It is the number that decides whether somebody stays invested — a fund can have an excellent ten-year return and still have been unbearable to hold in year four.

Every one-year period it has lived through

Rolling returns ask a fairer question than a single five-year figure: not "what did it do from this one start date", but "what happened across every start date". A fund whose worst year is −45% is a different proposition from one whose worst is −8%, even if the averages match.

Calendar years

What it actually holds

The real portfolio the AMC filed with AMFI, as on 30 Sep 2026. Nothing here is estimated — when a fund has no filing in our store the section simply does not appear. A fund is its holdings; the returns above are only what those holdings did.

Asset allocation

A fund's risk starts here — how much of it is even in the market — before any question of which stocks or which sectors. Cash is not idleness; it is the manager's choice not to be invested, and it shows up as a drag in a rising market and a cushion in a falling one.

Sector allocation

Largest holdings

Top 10 are 49.2% of the fund. A high number means a concentrated portfolio — fewer names doing more of the work, for better and for worse.

Disclosed holdings from the AMC's AMFI filing, largest first. A portfolio is filed monthly and shifts between filings — this is the most recent one loaded, not a live book.

What the manager did last month

Between the filing of 31 Aug 2026 and 30 Sep 2026. A position grows for two reasons — the manager bought more, or the price went up — and only the first is a decision. The share count is what separates them, because it moves only when somebody trades.

Swipe the table sideways for share counts, price change and values.

Only stocks and fund units are listed. Treasury bills, repo and money-market lines roll over every month by design — they are larger in rupees than most equity trades and are not decisions, so they are summarised as cash above rather than listed as activity. Share counts and values are the fund house's own filing. What a position cost when it was first bought is in no monthly disclosure, so a value here is what the shares were worth at the later filing, not what was paid.

One caveat on the share count: a corporate action — a stock split, a bonus issue, a merger, or an ISIN change — also moves the number of shares without the manager trading, and a monthly disclosure does not flag it. A sudden clean multiple (a doubling, a halving) is more likely a split than a decision. Treat a single large, round jump as something to check against the stock's own corporate-action history rather than as the manager buying or selling.

How it compares in its category

Against the Sectoral / Thematic Regular schemes with the highest three-year return. Same category, same plan — the only comparison that means anything. The list re-sorts itself as returns move; it is an ordering by one number, not a view on which fund anyone should hold.